Freenome Vallania Study Additional Inclusion & Exclusion Criteria

Control

Cohort

No additional criteria

Liver Cancer Subject must be diagnosed with HCC or have a presumptive diagnosis of or high clinical suspicion for HCC by imaging (e.g., CT, MRI) and have not yet received any cancer treatment (including but not limited to surgery, chemotherapy, and/or radiation)

Lung Cancer Subject must be diagnosed with pathologically-confirmed lung cancer (i.e., adenocarcinoma, squamous cell carcinoma, large cell carcinoma, small cell carcinoma) or have a presumptive diagnosis of or high clinical suspicion for the same by imaging (e.g., CT, MRI, PET) and have not yet received any cancer treatment (including but not limited to surgery, chemotherapy, and/or radiation)

Ovarian Cancer Subject must be diagnosed with histologically-confirmed serous or endometrioid ovarian cancer, fallopian tube cancer or primary peritoneal cancer, or have a presumptive diagnosis of or high clinical suspicion for the same by imaging (e.g., CT, MRI, PET or ultrasound) and have not yet received any cancer treatment (including but not limited to surgery, chemotherapy, and/or radiation)

Pancreatic Cancer Subject must be diagnosed with pathologically-confirmed pancreatic cancer (i.e., adenocarcinoma, acinar cell carcinoma, cystadenocarcinomas, and mucinous cystic neoplasms) or have a presumptive diagnosis of or high clinical suspicion for the same by imaging (e.g., CT, MRI, PET or ultrasound) and have not yet received any cancer treatment (including but not limited to surgery, chemotherapy, and/or radiation)